Shares of Zydus Lifesciences Ltd ended at ₹901.60, down by ₹40.85, or 4.33% on the BSE. Previous Post Bajaj Consumer Care Q3 Results | Net profit slides 30%; approves 100% acquisition of Vishal Personal Care Next Post Easy Trip Q3 Results | Net profit, margin decline despite 172% rise in hotel bookings Leave a ReplyCancel ReplyYour email address will not be published. Required fields are marked * Name * Email * Website Add Comment * Save my name, email and website in this browser for the next time I comment.Post Comment
